Intresseorganisationer
Projektets/aktivitetens namn:
SSc Advisory Board MeetingTidplan/datum:
Startdatum: 2022-05-11Slutdatum: 2022-09-30
Läkemedelsföretag:
Boehringer Ingelheim AB (ansvarar för innehållet i denna text)Samarbetspartner:
Systemisk skleros Sweden/ FESCA – Federation of European Scleroderma associationsProjektbeskrivning:
Understand patient and caregiver needs and expectations;Raise patient satisfaction with our trials, medicines and support services;Enhance disease awareness and patient information;Understand and support the objectives of patient organizationsEkonomi – Beskrivning:
2500 SEK, Fee for serviceÖvrigt:
Kontaktpersoner:
Boehringer Ingelheim AB, Robina Weermeijer, +31 (72) 566-2324, robina.weermeijer@boehringer-ingelheim.comSystemisk skleros Sweden/ FESCA – Federation of European Scleroderma associations, Monica Holmner, 08-505 805 00, monica.holmner@gmail.com